Osaic Holdings
URGN icon

Osaic Holdings’s UroGen Pharma URGN Stock Holding History

Osaic Holdings’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$83.5K Sell
2,270
-647
-22% -$17.5K ﹤0.01% 5097
2026
Q1 		$52.4K Buy
2,917
+2
+0.1% +$40 ﹤0.01% 5176
2025
Q4 		$68.3K Sell
2,915
-11,975
-80% -$260K ﹤0.01% 5019
2025
Q3 		$287K Buy
14,890
+11,195
+303% +$201K ﹤0.01% 3913
2025
Q2 		$50.3K Buy
3,695
+3,070
+491% +$29.5K ﹤0.01% 5051
2025
Q1 		$6.91K Sell
625
-1,044
-63% -$11.1K ﹤0.01% 5999
2024
Q4 		$17.8K Buy
1,669
+1,057
+173% +$12.7K ﹤0.01% 5423
2024
Q3 		$7.77K Buy
612
+202
+49% +$3K ﹤0.01% 5970
2024
Q2 		$6.88K Sell
410
-253
-38% -$3.6K ﹤0.01% 6012
2024
Q1 		$9.95K Hold
663
– – ﹤0.01% 5743
2023
Q4 		$9.95K Sell
663
-543
-45% -$7.05K ﹤0.01% 5831
2023
Q3 		$16.9K Buy
1,206
+586
+95% +$9.41K ﹤0.01% 5635
2023
Q2 		$6.42K Hold
620
– – ﹤0.01% 6193
2023
Q1 		$5.73K Sell
620
-20
-3% -$184 ﹤0.01% 6262
2022
Q4 		$5K Buy
640
+20
+3% +$189 ﹤0.01% 6313
2022
Q3 		$5K Hold
620
– – ﹤0.01% 6396
2022
Q2 		$5K Buy
620
+120
+24% +$824 ﹤0.01% 6506
2022
Q1 		$4K Hold
500
– – ﹤0.01% 6642
2021
Q4 		$5K Buy
+500
New +$7.05K ﹤0.01% 6663

Other funds holding URGN

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Osaic Holdings's URGN Position: Q2 2026 in Review

Osaic Holdings reduced its UroGen Pharma (URGN) stake by 22% in Q2 2026, selling an estimated $17.5K and leaving 2,270 shares worth $83.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5097.

Osaic Holdings first reported a position in URGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $287K in Q3 2025. 189 funds tracked by Wall St. Rank hold URGN as of Q2 2026.

  • Osaic Holdings held 2,270 shares of UroGen Pharma worth $83.5K as of Q2 2026.
  • Osaic Holdings sold 647 UroGen Pharma shares in Q2 2026, an estimated $17.5K.
  • UroGen Pharma made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5097 holding.
  • Osaic Holdings first reported a position in UroGen Pharma in Q4 2021 and has held it in 19 quarters since.
  • Osaic Holdings's UroGen Pharma position peaked at $287K in Q3 2025.
  • 189 funds tracked by Wall St. Rank held UroGen Pharma as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.